Pfizer Wins Challenge |To Two Celebrex Patents

     WASHINGTON (CN) – The Federal Circuit ruled for Pfizer on two of three patent claims covering the anti-inflammatory Celebrex that were challenged by the generic drug manufacturer Teva Pharmaceuticals USA. The three-judge panel found that two of the patents were valid, while the third was invalid due to double patenting.

%d bloggers like this: